Studies conducted in PCa patients have shown that ET is an important strategy that can be used to mitigate PCa-related clinical features, such as lower circulating glucose and insulin levels, increased adipose tissue mass, and whole-body inflammatory markers as well as improving hormonal levels [15,16,108]. This evidence concerns the gene INS and posterior cortical atrophy.